These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 30142879)

  • 1. Roles of the TGF-β⁻VEGF-C Pathway in Fibrosis-Related Lymphangiogenesis.
    Kinashi H; Ito Y; Sun T; Katsuno T; Takei Y
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Connective tissue growth factor is correlated with peritoneal lymphangiogenesis.
    Kinashi H; Toda N; Sun T; Nguyen TQ; Suzuki Y; Katsuno T; Yokoi H; Aten J; Mizuno M; Maruyama S; Yanagita M; Goldschmeding R; Ito Y
    Sci Rep; 2019 Aug; 9(1):12175. PubMed ID: 31434958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 promotes lymphangiogenesis during peritoneal fibrosis.
    Kinashi H; Ito Y; Mizuno M; Suzuki Y; Terabayashi T; Nagura F; Hattori R; Matsukawa Y; Mizuno T; Noda Y; Nishimura H; Nishio R; Maruyama S; Imai E; Matsuo S; Takei Y
    J Am Soc Nephrol; 2013 Oct; 24(10):1627-42. PubMed ID: 23990681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.
    Davydova N; Harris NC; Roufail S; Paquet-Fifield S; Ishaq M; Streltsov VA; Williams SP; Karnezis T; Stacker SA; Achen MG
    J Biol Chem; 2016 Dec; 291(53):27265-27278. PubMed ID: 27852824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Connective tissue growth factor regulates fibrosis-associated renal lymphangiogenesis.
    Kinashi H; Falke LL; Nguyen TQ; Bovenschen N; Aten J; Leask A; Ito Y; Goldschmeding R
    Kidney Int; 2017 Oct; 92(4):850-863. PubMed ID: 28545716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
    Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
    Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential mRNA and tissue expression of lymphangiogenic growth factors (VEGF-C and -D) and their receptor (VEGFR-3) during tail regeneration in a gecko.
    Blacker HA; Orgeig S
    J Comp Physiol B; 2012 Jan; 182(1):109-26. PubMed ID: 21800152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma.
    Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z
    Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble vascular endothelial growth factor receptor-3 suppresses lymphangiogenesis and lymphatic metastasis in bladder cancer.
    Yang H; Kim C; Kim MJ; Schwendener RA; Alitalo K; Heston W; Kim I; Kim WJ; Koh GY
    Mol Cancer; 2011 Apr; 10():36. PubMed ID: 21481239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan-induced VEGF-C promotes fibrosis-induced lymphangiogenesis via Toll-like receptor 4-dependent signal pathway.
    Jung YJ; Lee AS; Nguyen-Thanh T; Kang KP; Lee S; Jang KY; Kim MK; Kim SH; Park SK; Kim W
    Biochem Biophys Res Commun; 2015 Oct; 466(3):339-45. PubMed ID: 26362177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The tyrosine kinase inhibitor cediranib blocks ligand-induced vascular endothelial growth factor receptor-3 activity and lymphangiogenesis.
    Heckman CA; Holopainen T; Wirzenius M; Keskitalo S; Jeltsch M; Ylä-Herttuala S; Wedge SR; Jürgensmeier JM; Alitalo K
    Cancer Res; 2008 Jun; 68(12):4754-62. PubMed ID: 18559522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular control of lymphatic metastasis.
    Achen MG; Stacker SA
    Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle.
    Kivelä R; Silvennoinen M; Lehti M; Kainulainen H; Vihko V
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2573-9. PubMed ID: 17766486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction.
    Suzuki Y; Ito Y; Mizuno M; Kinashi H; Sawai A; Noda Y; Mizuno T; Shimizu H; Fujita Y; Matsui K; Maruyama S; Imai E; Matsuo S; Takei Y
    Kidney Int; 2012 May; 81(9):865-79. PubMed ID: 22258325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor-C and -D are involved in lymphangiogenesis in mouse unilateral ureteral obstruction.
    Lee AS; Lee JE; Jung YJ; Kim DH; Kang KP; Lee S; Park SK; Lee SY; Kang MJ; Moon WS; Kim HJ; Jeong YB; Sung MJ; Kim W
    Kidney Int; 2013 Jan; 83(1):50-62. PubMed ID: 22932121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
    Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
    Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.
    Hosono K; Suzuki T; Tamaki H; Sakagami H; Hayashi I; Narumiya S; Alitalo K; Majima M
    Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1049-58. PubMed ID: 21311040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.